Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.

Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G, Peetermans M, Stryckmans P, Willemze R, Feremans W, Jaksic B, Bourhis JH, Burghouts JP, de Witte T; EORTC Leukemia Group.

Haematologica. 2004 Jul;89(7):809-17.

2.

Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.

Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.

Semin Oncol. 2000 Apr;27(2 Suppl 5):52-7.

PMID:
10877053
3.

Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.

Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.

Ann Oncol. 1999 Dec;10(12):1493-8.

PMID:
10643542
4.

TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.

Lagneaux L, Delforge A, Bernier M, Stryckmans P, Bron D.

Leuk Lymphoma. 1998 Sep;31(1-2):99-106. Review.

PMID:
9720719
5.

Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation.

Trenschel R, Bernier M, Delforge A, Massy M, Lebeau De Hemricourt E, Maerevoet M, Badjou R, Stryckmans P, Bron D.

Leuk Lymphoma. 1998 Jul;30(3-4):325-52.

PMID:
9713964
6.

Increased incidence of lymphomas and carcinomas in patients with coeliac disease.

Bleiberg H, Duchateau J, N'Koua M'Bon JB, Gerard B, Bron D, Debusscher L, Stryckmans P.

Eur J Cancer. 1998 Mar;34(4):592-3. No abstract available.

PMID:
9713317
7.
8.
9.

Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia.

Archimbaud E, Michallet M, Philip I, Charrin C, Clapisson G, Belhabri A, Guilhot F, Stryckmans P, Adeleine P, Fière D.

Br J Haematol. 1997 Dec;99(3):678-84.

PMID:
9401084
10.
11.

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial.

Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R.

Bone Marrow Transplant. 1997 Aug;20(4):307-15.

12.
13.

Ex vivo expansion of CD34 + CD38- cord blood cells.

De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, De Hemptinne D, Stryckmans P.

J Hematother. 1997 Apr;6(2):93-102.

PMID:
9131438
14.

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).

Willemze R, Suciu S, Archimbaud E, Muus P, Stryckmans P, Louwagie EA, Berneman Z, Tjean M, Wijermans P, Dohner H, Jehn U, Labar B, Jaksic B, Dardenne M, Zittoun R.

Leukemia. 1997 Mar;11 Suppl 1:S24-7.

PMID:
9130688
15.

Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation.

Trenschel R, Bernier M, Stryckmans P, Verhest A, Badjou R, Crombez P, Bron D.

Bone Marrow Transplant. 1997 Feb;19(4):381-3.

16.

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.

Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D.

Blood. 1996 Dec 1;88(11):4259-64.

17.

Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection.

Lagneaux L, Delforge A, Snoeck R, Bosmans E, Schols D, De Clereq E, Stryckmans P, Bron D.

J Infect Dis. 1996 Nov;174(5):913-9.

PMID:
8896490
18.

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

Zittoun R, Suciu S, Mandelli F, de Witte T, Thaler J, Stryckmans P, Hayat M, Peetermans M, Cadiou M, Solbu G, Petti MC, Willemze R.

J Clin Oncol. 1996 Jul;14(7):2150-9.

PMID:
8683249
19.

Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells.

Praet M, Stryckmans P, Ruysschaert JM.

Biochem Pharmacol. 1996 May 17;51(10):1341-8.

PMID:
8787550
20.

Very low level of major BCR-ABL expression in blood of some healthy individuals.

Biernaux C, Sels A, Huez G, Stryckmans P.

Bone Marrow Transplant. 1996 May;17 Suppl 3:S45-7.

PMID:
8769701
21.

Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells.

Lagneaux L, Delforge A, Snoeck R, Bosmans E, Moreau JF, Taupin JL, De Clercq E, Stryckmans P, Bron D.

Blood. 1996 Jan 1;87(1):59-66.

22.

Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals.

Biernaux C, Loos M, Sels A, Huez G, Stryckmans P.

Blood. 1995 Oct 15;86(8):3118-22.

23.

Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.

De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley P, de Hemptinne D, Stryckmans P.

Stem Cells. 1995 May;13(3):281-8.

PMID:
7613494
24.

Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.

Lagneaux L, Delforge A, Bron D, Bosmans E, Stryckmans P.

Leuk Lymphoma. 1995 Mar;17(1-2):127-33.

PMID:
7773149
25.

Immunological definition of acute minimally differentiated myeloid leukemia (MO) and acute undifferentiated leukemia (AUL).

Bernier M, Massy M, Deleeuw N, Bron D, Debusscher L, Stryckmans P.

Leuk Lymphoma. 1995;18 Suppl 1:13-7.

PMID:
7496349
26.

Tumour stimulating effects of recombinant human interleukin-6.

Ravoet C, DeGrève J, Vandewoude K, Kerger J, Sculier JP, Lacor P, Stryckmans P, Piccart M.

Lancet. 1994 Dec 3;344(8936):1576-7. No abstract available.

PMID:
7983975
28.

EORTC-GIMEMA AML8 protocol. A phase III study on autologous bone-marrow transplantation in acute myelogenous leukemia (AML).

Zittoun R, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, Ferrini PR, Visani G, Caronia F, Stryckmans P, et al.

Leuk Lymphoma. 1994;13 Suppl 1:101. No abstract available.

PMID:
8075572
29.

Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.

Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D.

Exp Hematol. 1994 Jan;22(1):26-30.

PMID:
7506672
31.

Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work.

Razavi D, Delvaux N, Brédart A, Autier P, Bron D, Debusscher L, Stryckmans P.

Support Care Cancer. 1993 Sep;1(5):276-8.

PMID:
8156241
32.

Interferon in chronic myeloid leukemia. A workshop report.

Griesshammer M, Hehlmann R, Hochhaus A, Talpaz M, Tura S, Stryckmans P, Allan NC, Tanzer J, Kolb HJ, Heimpel H.

Ann Hematol. 1993 Aug;67(2):101-6. Review.

PMID:
8347729
33.

Cytomegalovirus-mediated myelosuppression.

Lagneaux L, Delforge A, Stryckmans P, Bron D.

Exp Hematol. 1993 Jul;21(7):837-8. No abstract available.

PMID:
8391469
34.

Efficacy and safety of cytokines for human therapy. Report of an EC Study Group.

Stryckmans P, Duff GW, Fracchia GN.

Cytokine. 1993 May;5(3):180-4. No abstract available.

PMID:
8218928
35.

Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.

Döhner H, Ho AD, Thaler J, Stryckmans P, Sonneveld P, de Witte T, Lechner K, Lauria F, Bödewadt-Radzun S, Suciu S, et al.

J Natl Cancer Inst. 1993 Apr 21;85(8):658-62.

PMID:
8468724
36.

[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].

Zittoun R, Rio B, Delmer A, Vekhof A, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P, et al.

Nouv Rev Fr Hematol. 1993 Feb;35(1):15-6. French. No abstract available.

PMID:
8511034
37.

Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells.

van Bockstaele DR, Lenjou M, Snoeck HW, Lardon F, Stryckmans P, Peetermans ME.

Ann Hematol. 1993 Feb;66(2):61-6.

PMID:
7680579
38.

Modulation of the growth of hematopoietic human stem cells by growth factors: comparison of umbilical cord blood with bone marrow.

DeBruyn C, Stryckmans P, Bron D, Ley P, Degueldre M, Delforge A.

J Hematother. 1993 Summer;2(2):241-2.

PMID:
7522879
39.

[Current perspectives in bone marrow transplantation].

Stryckmans P.

Rev Med Brux. 1992 Jun;13(6):223-7. French.

PMID:
1352906
40.

[Bone marrow autograft in malignant hemopathies. The Team of the Sterile Unit].

Bron D, Debusscher L, Bernier M, Badjou R, Crombez P, Stryckmans P.

Rev Med Brux. 1992 May;13(5):167-71. Review. French.

PMID:
1609191
41.

[Bone marrow grafts. Introduction].

Stryckmans P.

Rev Med Brux. 1992 May;13(5):143-4, 147-8, 151. Review. French.

PMID:
1609188
42.

Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.

Stryckmans P, De Witte T, Marie JP, Fillet G, Peetermans M, Bury J, Muus P, Andrien JM, Hayat M, Jaksic B, et al.

Leukemia. 1992;6 Suppl 2:199-203. No abstract available.

PMID:
1578934
43.

Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.

Zittoun R, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P, Gattringer C, Petti MC, Solbu G, et al.

Leukemia. 1992;6 Suppl 2:114-5. No abstract available.

PMID:
1578909
44.

Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction.

Bieva C, Martiat P, Ferster A, Sariban E, Kedar A, Erdos G, Bron D, Debusscher L, Stryckmans P.

Prog Clin Biol Res. 1992;377:197-204. No abstract available.

PMID:
1438416
45.

Screening for psychiatric disorders in a lymphoma out-patient population.

Razavi D, Delvaux N, Bredart A, Paesmans M, Debusscher L, Bron D, Stryckmans P.

Eur J Cancer. 1992;28A(11):1869-72.

PMID:
1389529
46.

Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model.

Bron D, Lagneaux L, Delforge A, Otte C, Snoeck R, Stryckmans P.

Exp Hematol. 1991 Feb;19(2):132-5.

PMID:
1846820
47.

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Delforge A, Bernier M, Bosmans E, Massy M, Bron D, Heyligen H, Raus J, Mendes Da Costa P, Stryckmans P.

Leuk Lymphoma. 1991;3(5-6):385-93. doi: 10.3109/10428199109070282.

PMID:
27467429
48.

Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy.

Bieva CJ, Mosselmans R, Brugghen FV, Kedar A, Erdos G, Fruhling J, Stryckmans P, Galand P.

Leuk Lymphoma. 1991;6(1):75-81. doi: 10.3109/10428199109064882.

PMID:
27457579
49.

Chemotherapy of adult acute lymphoblastic leukaemia.

Stryckmans P, Debusscher L.

Baillieres Clin Haematol. 1991 Jan;4(1):115-30. Review. No abstract available.

PMID:
2039854
50.

Analysis of interferon-inducible genes in cells of chronic myeloid leukemia patients responsive or resistant to an interferon-alpha treatment.

Clauss IM, Vandenplas B, Wathelet MG, Dorval C, Delforge A, Content J, Stryckmans P, Huez GA.

Blood. 1990 Dec 1;76(11):2337-42.

Supplemental Content

Loading ...
Support Center